dacarbazine and withaferin a

dacarbazine has been researched along with withaferin a in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MS; Grogan, PT; Sarkaria, JN; Timmermann, BN1

Other Studies

1 other study(ies) available for dacarbazine and withaferin a

ArticleYear
Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.
    Investigational new drugs, 2014, Volume: 32, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; ErbB Receptors; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Heme Oxygenase-1; Humans; MAP Kinase Signaling System; O(6)-Methylguanine-DNA Methyltransferase; Oxidative Stress; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Receptor, ErbB-2; Ribosomal Protein S6 Kinases, 70-kDa; Temozolomide; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins; Withanolides

2014